Real-world data on the survival outcome of patients with newly diagnosed Waldenström macroglobulinemia

BACKGROUND/AIMS: Waldenström macroglobulinemia (WM) is a rare lymphoproliferative disorder that usually follows an indolent clinical course. However, some patients show an aggressive clinical course leading to death. We explored the risk factors predicting poor prognosis in WM patients. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Jang Ho, Shim, Joon-Ho, Yoon, Sang Eun, Kim, Hee-Jin, Kim, Sun-Hee, Ko, Young Hyeh, Lee, Seung-Tae, Kim, Kihyun, Kim, Won Seog, Kim, Seok Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137404/
https://www.ncbi.nlm.nih.gov/pubmed/32791817
http://dx.doi.org/10.3904/kjim.2019.367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137404/
https://www.ncbi.nlm.nih.gov/pubmed/32791817
http://dx.doi.org/10.3904/kjim.2019.367

Ejemplares similares